Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD

BACKGROUND: Patients with inflammatory bowel disease (IBD) have intestinal inflammation and are treated with immune-modulating medications. In the face of the coronavirus disease-19 pandemic, we do not know whether patients with IBD will be more susceptible to infection or disease. We hypothesized t...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Inflamm Bowel Dis
Главные авторы: Burgueño, Juan F, Reich, Adrian, Hazime, Hajar, Quintero, Maria A, Fernandez, Irina, Fritsch, Julia, Santander, Ana M, Brito, Nivis, Damas, Oriana M, Deshpande, Amar, Kerman, David H, Zhang, Lanyu, Gao, Zhen, Ban, Yuguang, Wang, Lily, Pignac-Kobinger, Judith, Abreu, Maria T
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Leading Off
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7188157/
https://ncbi.nlm.nih.gov/pubmed/32333601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izaa085
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы